18th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170119704 | TREATMENT OF COGNITIVE IMPAIRMENT | 2017-05-04 |
20170119705 | Oral Composition | 2017-05-04 |
20170119706 | Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA Receptor | 2017-05-04 |
20170119707 | HOMEOPATHIC TOPICAL GEL FOR TRANSDERMAL DELIVERY OF COLCHICINE FORMULATIONS AND METHOD OF USE | 2017-05-04 |
20170119708 | METHODS AND COMPOSITIONS FOR MODULATING MUSCLE AND BONE LOSS | 2017-05-04 |
20170119709 | METHOD OF TREATMENT FOR THIRD SPACING | 2017-05-04 |
20170119710 | TREATMENT OF CONDITIONS RELATED TO SHOCK | 2017-05-04 |
20170119711 | ALL-NATURAL ENTERIC SOFT CAPSULES | 2017-05-04 |
20170119712 | METHODS AND COMPOSITIONS FOR IMPROVING MICROVASCULAR FUNCTION, SUPPRESSING CYCLOOXYGENASE ACTIVITY, REDUCING PLATELET AGGREGATION AND INCREASING LEVELS OF RESVERATROL IN PLASMA | 2017-05-04 |
20170119713 | TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2017-05-04 |
20170119714 | TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2017-05-04 |
20170119715 | THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE PRECURSORS | 2017-05-04 |
20170119716 | Position-Specific Asymmetric Deuterium Enriched Catecholamine Derivatives And Medicaments Comprising Said Compounds | 2017-05-04 |
20170119717 | NITRATED LIPIDS AND METHODS OF MAKING AND USING THEREOF | 2017-05-04 |
20170119718 | METHODS AND COMPOSITIONS FOR IMPROVING MICROVASCULAR FUNCTION, SUPPRESSING CYCLOOXYGENASE ACTIVITY, REDUCING PLATELET AGGREGATION AND INCREASING LEVELS OF RESVERATROL IN PLASMA | 2017-05-04 |
20170119719 | ADMINISTRATION OF INGENOL MEBUTATE | 2017-05-04 |
20170119720 | HOMOGENEOUS FORMULATION COMPRISING OMEGA-3 POLYUNSATURED FATTY ACID AND RESVERATROL FOR ORAL ADMINISTRATION | 2017-05-04 |
20170119721 | COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND A HYDROXYL COMPOUND AND METHODS OF USE THEREOF | 2017-05-04 |
20170119722 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2017-05-04 |
20170119723 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY | 2017-05-04 |
20170119724 | SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID | 2017-05-04 |
20170119725 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN | 2017-05-04 |
20170119726 | Stabilized Cabazitaxel Formulations | 2017-05-04 |
20170119727 | A THERAPEUTIC PROTOCOL FOR TREATING OVARIAN CANCER | 2017-05-04 |
20170119728 | Edible Base Product Composition | 2017-05-04 |
20170119729 | COMPOUNDS INFLUENCING FATTY ACID UPTAKE AND METABOLISM AND THE PRODUCTION OF INFLAMMATORY AGENTS AND METHODS OF ISOLATING THEM FROM COCOA PRODUCTS | 2017-05-04 |
20170119730 | Combination Therapy for Effecting Weight Loss and Treating Obesity | 2017-05-04 |
20170119731 | CDC7 KINASE INHIBITORS AND USES THEREOF | 2017-05-04 |
20170119732 | METHODS FOR SCAR PREVENTION | 2017-05-04 |
20170119733 | Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases | 2017-05-04 |
20170119734 | TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE | 2017-05-04 |
20170119735 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | 2017-05-04 |
20170119736 | COMPOUND HAVING HIGHER INHIBITORY ACTIVITY ON PROTEIN KINASE G AND PREPARATION METHOD THEREOF | 2017-05-04 |
20170119737 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | 2017-05-04 |
20170119738 | PHARMACEUTICAL COMPOSITIONS FOR RIZATRIPTAN | 2017-05-04 |
20170119739 | METHOD FOR IMPROVING PHARMACOKINETICS | 2017-05-04 |
20170119740 | Methods for Treating Cancer by Activation of BMP Signaling | 2017-05-04 |
20170119741 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | 2017-05-04 |
20170119742 | MEDICAMENT FOR PREVENTING AND/OR TREATING STRESS DISEASES | 2017-05-04 |
20170119743 | AZAINDOLE DERIVATIVE | 2017-05-04 |
20170119744 | Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent | 2017-05-04 |
20170119745 | METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OX- O-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CERTAIN HEMATOLOGIC DISORDERS | 2017-05-04 |
20170119746 | PREPARATION AND THERAPEUTIC APPLICATIONS OF (2S,3R)-N-2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)-3,5-DIFLUO- ROBENZAMIDE | 2017-05-04 |
20170119747 | METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING PI3K/AKT/MTOR SIGNALING PATHWAY | 2017-05-04 |
20170119748 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES | 2017-05-04 |
20170119750 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | 2017-05-04 |
20170119751 | AURORA A KINASE INHIBITOR | 2017-05-04 |
20170119752 | NICOTINIC ATTENUATION OF CNS INFLAMMATION AND AUTOIMMUNITY | 2017-05-04 |
20170119753 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2017-05-04 |
20170119755 | PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE | 2017-05-04 |
20170119756 | PHARMACEUTICAL FORMULATION CONTAINING IRRITANT | 2017-05-04 |
20170119757 | Methods for Treating Antipsychotic-Induced Weight Gain | 2017-05-04 |
20170119758 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | 2017-05-04 |
20170119759 | PHARMACEUTICAL FORMULATION OF N-[5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-2H-PYRAZOL-3-YL]-4-[(3R,5S)-3,5-DIMET- HYLPIPERAZIN-1-YL]BENZAMIDE | 2017-05-04 |
20170119760 | USE OF MASITINIB FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY | 2017-05-04 |
20170119761 | SUBSTITUTED 3-BENZOFURANYL-INDOL-2-ONE-3-ACETAMIDIDOPIPERAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF | 2017-05-04 |
20170119762 | LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS | 2017-05-04 |
20170119763 | COMBINATIONS | 2017-05-04 |
20170119764 | POLYCYCLICCARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE | 2017-05-04 |
20170119765 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-IH-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | 2017-05-04 |
20170119766 | Methods for Treating Cancer Using Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity | 2017-05-04 |
20170119767 | PHARMACEUTICAL COMPOSITIONS FOR SUBSTITUTED QUINAZOLINONES | 2017-05-04 |
20170119768 | ANTI-ANGIOGENESIS COMPOUND, INTERMEDIATE AND USE THEREOF | 2017-05-04 |
20170119769 | SCAFFOLDS FOR INHIBITORS OF MENIN-MLL INTERACTIONS | 2017-05-04 |
20170119770 | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS | 2017-05-04 |
20170119771 | COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES | 2017-05-04 |
20170119772 | BEVERAGE COMPOSITION COMPRISING PHLOROTANNIN, GINSENG EXTRACT AND CAFFEINE | 2017-05-04 |
20170119773 | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION | 2017-05-04 |
20170119774 | Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation | 2017-05-04 |
20170119775 | TREATMENT OF COGNITIVE DISORDERS | 2017-05-04 |
20170119776 | CHIRAL 2,5-DISUBSTITUTED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND USE THEREOF | 2017-05-04 |
20170119777 | ANTIVIRAL THERAPY | 2017-05-04 |
20170119778 | TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS | 2017-05-04 |
20170119779 | RETOSIBAN FOR THE TREATMENT OF PRE-TERM LABOUR | 2017-05-04 |
20170119780 | ARYL- OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 2017-05-04 |
20170119781 | PHARMACEUTICAL COMPOSITION COMPRISING NON-IONIC SURFACTANTS | 2017-05-04 |
20170119782 | BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS | 2017-05-04 |
20170119783 | Method for Treating Cognitive Impairment Associated With Neurodegenerative Disorders | 2017-05-04 |
20170119784 | NEW DERIVATIVES OF CEPHALOSPORIN FOR TREATING CANCER | 2017-05-04 |
20170119785 | SOL-GEL POLYMER COMPOSITES AND USES THEREOF | 2017-05-04 |
20170119786 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | 2017-05-04 |
20170119787 | MODULATING THE PRODUCTION OF NEURONS AND/OR OLIGODENDROCYTES FROM WHITE MATTER PROGENITOR CELLS | 2017-05-04 |
20170119788 | METHODS AND COMPOSITIONS FOR DERMATOLOGICAL USE COMPRISING FLUTICASONE AND MOMETASONE AND BIOPOLYMERS | 2017-05-04 |
20170119789 | METHODS FOR IMPROVING MEDICAL THERAPIES | 2017-05-04 |
20170119790 | Agents, Uses and Methods | 2017-05-04 |
20170119791 | METHODS AND COMPOSITIONS FOR DERMATOLOGICAL USE COMPRSING BETAMETHASONE AND BIOPOLYMERS | 2017-05-04 |
20170119792 | METHODS AND COMPOSITIONS FOR DERMATOLOGICAL USE COMPRISING CLOBETASOL AND HALOBETASOL AND BIOPOLYMERS | 2017-05-04 |
20170119793 | COMPOSITIONS AND METHODS FOR TREATING BONE AND JOINT INFECTIONS | 2017-05-04 |
20170119794 | TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF | 2017-05-04 |
20170119795 | FUSED TRITERPENE COMPOUNDS AND USES THEREOF | 2017-05-04 |
20170119796 | Spironolactone Aqueous Formulations | 2017-05-04 |
20170119797 | XYLITOL CONTAINING COMESTIBLE PRODUCT | 2017-05-04 |
20170119798 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | 2017-05-04 |
20170119799 | COMPOSITION OF DIALYSIS LIQUID COMPRISING CRYSTALLISATION INHIBITOR SUBSTANCES | 2017-05-04 |
20170119800 | STABILIZED LIQUID FOSAPREPITANT FORMULATIONS | 2017-05-04 |
20170119801 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2017-05-04 |
20170119802 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | 2017-05-04 |
20170119803 | NANOPARTICLE FORMULATIONS FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS | 2017-05-04 |
20170119804 | Composition Comprising a Combination of DNA Methylation Inhibitor and a Vitamin D Receptor Agonist for the Treatment of Drug Resistant Cancer or for the Prevention of Tumor Relapse | 2017-05-04 |
20170119805 | PROTON-MOTIVE FORCE STIMULATION TO POTENTIATE AMINOGLYCOSIDE ANTIBIOTICS AGAINST PERSISTENT BACTERIA | 2017-05-04 |